Aethlon Medical (AEMD) Shares Outstanding (Weighted Average) (2010 - 2026)

Aethlon Medical's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 1117.01% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 1117.01% YoY), and the FY2026 full-year result was $1.9 million, up 1117.01% from the prior year.
• Shares Outstanding (Weighted Average) was $1.9 million for Q1 2026 at Aethlon Medical, up from $1.1 million in the prior quarter.
• Over the last five years, Shares Outstanding (Weighted Average) for AEMD reached as high as $15.5 million in Q2 2022 and fell as low as $409.0 in Q1 2024.
• Median Shares Outstanding (Weighted Average) over the past 5 years was $2.0 million (2022), compared with a mean of $3.5 million.
• Across the five-year window, Shares Outstanding (Weighted Average) plunged 97.1% in 2022 and jumped 38062.59% in 2025, its largest moves.
• Over 5 years, Shares Outstanding (Weighted Average) stood at $2.0 million in 2022, then advanced by 27.47% to $2.5 million in 2023, then jumped by 430.75% to $13.4 million in 2024, then slumped by 91.63% to $1.1 million in 2025, then surged by 69.87% to $1.9 million in 2026.
• Business Quant data shows AEMD's Shares Outstanding (Weighted Average) at $1.9 million in Q1 2026, $1.1 million in Q4 2025, and $304960.0 in Q3 2025.